I don't think that retail trades are driving this stock. Let's put this in perspective. Look at the chart from mid-June. The market is waiting for a real catalyst to take this stock higher. The (admittedly weak) news has been priced in, and now what we need are real clinical results. Whether or not you think they are coming -- only you can decide based on research (and most certainly not on the ramblings on a Yahoo message board by people who somehow have enough time to post here every day claiming imminent drop back to $2s or a rush in price to the low teens). Good luck to all.